跳至主要内容
临床试验/JPRN-UMIN000007125
JPRN-UMIN000007125已完成未知

Oxygen Preconditioning Prevents Contrast-Induced Nephropathy - OPtion CI

Yokohama Medical Center (Department of Clinical Research)0 个研究点目标入组 400 人开始时间: 2012年1月24日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
400

研究概览

简要总结

The patient in the oxygen preconditioning group had significantly higher PaO2 (134.3 +- 27.7 vs. 90.1 +- 11.7 mmHg, P < 0.01) and significantly lesser incidence of CIN (0.6% vs. 6.1%, odds ratio 0.10, P = 0.01, 95% CI 0.01-0.75) comparing with those in the control group.

研究设计

研究类型
Interventional

入排标准

年龄范围
30years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • peritoneal dialysis, hemodialysis treatment, cardiogenic shock, congestive heart failure, pregnancy, a history of severe allergies to contrast media, recent major bleeding, having a metformin within 48 hours of the study entry, chronic obstructive pulmonary disease, patient with the oxygen saturation lesser than 90 percent, acute coronary syndrome, severe infection, severe malnutrition, post-operative states, pituitary or adrenal dysfunction, paraquat intoxication

研究者

发起方
Yokohama Medical Center (Department of Clinical Research)

相似试验